Phase 1 Study of the Pharmacology of BTI320 Before High-Glycemic Meals
{{output}}
BTI320 is a proprietary fractionated mannan polysaccharide being studied for attenuation of postprandial glucose excursion. The apparent blood glucose-lowering effect of this compound is effective in lowering postprandial hyperinsulinemia, participating in the... ...